Codes / ICD10CM / M10.19

M10.19 Lead-induced gout, multiple sites

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Common Name: Lead-induced gout, multiple sites
  • Technical Term: Lead-induced gout, multiple sites

Summary

Lead-induced gout, multiple sites is a form of arthritis caused by lead exposure, resulting in the deposition of urate crystals in multiple joints. Lead interferes with uric acid metabolism, leading to elevated uric acid levels and crystal formation. The condition is characterized by sudden, severe joint inflammation affecting more than one site.

Causes

Lead-induced gout, multiple sites occurs due to lead exposure, which disrupts uric acid excretion by the kidneys. This disruption causes uric acid to accumulate in the blood, leading to crystal deposition in multiple joints. Lead sources may include occupational exposure, contaminated water, or old paint.

Risk Factors

  • Occupational lead exposure (e.g., mining, battery manufacturing)
  • Environmental lead contamination (e.g., old plumbing, polluted soil)
  • Chronic lead ingestion (e.g., from lead-based paint or contaminated water)
  • Preexisting kidney dysfunction
  • High dietary purine intake
  • Male gender
  • Alcohol consumption

Symptoms

  • Sudden, intense joint pain in multiple sites
  • Swelling, redness, and warmth in affected joints
  • Tenderness to touch
  • Limited range of motion in affected joints
  • Possible kidney stone formation (due to lead-induced renal effects)

Diagnosis

Diagnosis involves a physical examination of affected joints, assessment of lead exposure history, and laboratory tests to measure blood uric acid levels and lead levels. Imaging may be used to evaluate joint damage or crystal deposition.

Treatment Options

Treatment focuses on reducing lead exposure, managing uric acid levels, and alleviating joint inflammation. This may include chelation therapy for lead removal, medications to lower uric acid (e.g., allopurinol), and anti-inflammatory drugs (e.g., NSAIDs) for pain relief. Joint rest and elevation may also be recommended.

Prognosis and Follow-Up

Prognosis depends on the extent of lead exposure and timely intervention. With proper treatment, symptoms can be controlled, but chronic lead exposure may lead to persistent joint issues. Regular follow-up is necessary to monitor uric acid levels, kidney function, and lead exposure reduction.

Complications

  • Chronic joint damage or deformity
  • Recurrent gout attacks
  • Kidney dysfunction or stones
  • Persistent lead toxicity if exposure continues

Lifestyle & Prevention

  • Avoid lead exposure by using protective equipment in occupational settings
  • Test water and soil for lead contamination
  • Maintain a low-purine diet to reduce uric acid production
  • Stay hydrated to support kidney function
  • Limit alcohol consumption, which can exacerbate uric acid levels

When to Seek Professional Help

Seek medical attention if you experience sudden, severe joint pain, swelling, or redness, especially if you have a history of lead exposure. Prompt evaluation is important to prevent complications and manage symptoms effectively.

Tips for Medical Coders

Document the specific joints affected and confirm lead exposure as the cause. Ensure the code M10.19 is used when gout involves multiple sites due to lead exposure. Include details on lead source (e.g., occupational, environmental) and any associated renal or systemic effects to support accurate coding.

Book a walkthrough

M10.19 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.